174 related articles for article (PubMed ID: 7509955)
21. Two subtypes of the endothelin receptor (ETA and ETB) mediate vasoconstriction in the perfused rat heart.
Balwierczak JL
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S248-51. PubMed ID: 7509957
[TBL] [Abstract][Full Text] [Related]
22. Evidence for ETA and ETB receptors in rat skin and an investigation of their function in the cutaneous microvasculature.
Lawrence E; Siney L; Wilsoncroft P; Knock GA; Terenghi G; Polak JM; Brain SD
Br J Pharmacol; 1995 Jul; 115(5):840-4. PubMed ID: 8548185
[TBL] [Abstract][Full Text] [Related]
23. Are there different ETB receptors mediating constriction and relaxation?
Clozel M; Gray GA
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S262-4. PubMed ID: 8587383
[TBL] [Abstract][Full Text] [Related]
24. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor.
Ihara M; Ishikawa K; Fukuroda T; Saeki T; Funabashi K; Fukami T; Suda H; Yano M
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S11-4. PubMed ID: 1282942
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic characterization of endothelin receptor responses in the isolated perfused rat lung.
Uhlig S; von Bethmann AN; Featherstone RL; Wendel A
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1449-60. PubMed ID: 7582276
[TBL] [Abstract][Full Text] [Related]
26. Coronary vasoconstriction by endothelin-1 in anesthetized goats: role of endothelin receptors, nitric oxide and prostanoids.
García JL; Fernández N; García-Villalón AL; Monge L; Gómez B; Diéguez G
Eur J Pharmacol; 1996 Nov; 315(2):179-86. PubMed ID: 8960882
[TBL] [Abstract][Full Text] [Related]
27. Predominance of endothelinA (ETA) receptors in ovine airway smooth muscle and their mediation of ET-1-induced contraction.
Goldie RG; Grayson PS; Knott PG; Self GJ; Henry PJ
Br J Pharmacol; 1994 Jul; 112(3):749-56. PubMed ID: 7921598
[TBL] [Abstract][Full Text] [Related]
28. Role of endothelins in regulation of vascular tone in the in situ perfused rat adrenals.
Mazzocchi G; Malendowicz LK; Musajo FG; Gottardo G; Markowska A; Nussdorfer GG
Am J Physiol; 1998 Jan; 274(1):E1-5. PubMed ID: 9458740
[TBL] [Abstract][Full Text] [Related]
29. Systemic hemodynamic and regional circulatory effects of centrally administered endothelin-1 are mediated through ETA receptors.
Rebello S; Roy S; Saxena PR; Gulati A
Brain Res; 1995 Apr; 676(1):141-50. PubMed ID: 7796163
[TBL] [Abstract][Full Text] [Related]
30. Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats.
Cavarape A; Endlich K; Feletto F; Parekh N; Bartoli E; Steinhausen M
Kidney Int; 1998 Apr; 53(4):963-9. PubMed ID: 9551405
[TBL] [Abstract][Full Text] [Related]
31. Distribution of endothelin-1-receptor subtypes in rat portal vein.
Filippelli A; Falciani M; Palla A; D'Amico M; Vacca C; Rossi F
J Cardiovasc Pharmacol; 1996 Jan; 27(1):113-18. PubMed ID: 8656643
[TBL] [Abstract][Full Text] [Related]
32. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat.
Gellai M; Fletcher T; Pullen M; Nambi P
Am J Physiol; 1996 Jul; 271(1 Pt 2):R254-61. PubMed ID: 8760228
[TBL] [Abstract][Full Text] [Related]
34. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
Pollock DM; Opgenorth TJ
Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists.
Awane-Igata Y; Ikeda S; Watanabe T
Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758
[TBL] [Abstract][Full Text] [Related]
36. Pharmacology of endothelins in vascular circuits of normal or heterozygous endothelin-A or endothelin-B knockout transgenic mice.
Berthiaume N; Yanagisawa M; Yanagisawa H; deWit D; D'Orléans-Juste P
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S561-4. PubMed ID: 9595543
[TBL] [Abstract][Full Text] [Related]
37. Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat.
D'Orléans-Juste P; Claing A; Warner TD; Yano M; Télémaque S
Br J Pharmacol; 1993 Oct; 110(2):687-92. PubMed ID: 8242241
[TBL] [Abstract][Full Text] [Related]
38. A new endothelin receptor antagonist, TAK-044, shows long-lasting inhibition of both ETA- and ETB-mediated blood pressure responses in rats.
Ikeda S; Awane Y; Kusumoto K; Wakimasu M; Watanabe T; Fujino M
J Pharmacol Exp Ther; 1994 Aug; 270(2):728-33. PubMed ID: 8071866
[TBL] [Abstract][Full Text] [Related]
39. Endothelin receptor mediated constriction and dilatation in feline cerebral resistance arterioles in vivo.
Patel TR; McAuley MA; McCulloch J
Eur J Pharmacol; 1996 Jun; 307(1):41-8. PubMed ID: 8831102
[TBL] [Abstract][Full Text] [Related]
40. Effects of selective endothelin antagonists on the hemodynamic response to cyclosporin A.
Davis LS; Haleen SJ; Doherty AM; Cody WL; Keiser JA
J Am Soc Nephrol; 1994 Jan; 4(7):1448-54. PubMed ID: 8161726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
